Quinolone

&fluoroquinolone

Folate biosythesis inhibitor

Phenicol

Tetracyline

Aminoglycosides

Beta-Lactamase Inhibitor

N (%)

O.R

P.V

N (%)

O.R

P.V

N (%)

O.R

P.V

N (%)

O.R

P.V

N (%)

O.R

P.V

N (%)

O.R

P.V

Gender

Male

33 (49.25)

0.84

0.54

122 (53.28)

1.07

0.73

59 (57.28)

1.3

0.26

56 (48.28)

0.77

0.26

134 (19.81)

0.65

0.07

69 (51.11)

0.91

0.66

Female

34 (50.75)

R

-

107 (46.72)

R

-

44 (42.72)

R

-

60 (51.70)

R

-

135 (50.19)

R

-

66 (48.89)

R

-

Residence

MN

26 (38.81)

1.67

0.07

86 (37.50)

-

-

40 (38.83)

1.81

0.02

54 (46.55)

3.14

0.00

97 (36.06)

4.35

0.00

61 (45.19)

3.2

0.00

MR

9 (13.43)

R

-

44 (19.21)

-

-

19 (18.45)

R

-

13 (11.21)

R

-

52 (19.33)

R

-

21 (15.56)

R

-

VU

32 (47.76)

-

-

99 (43.23)

-

-

44 (42.72)

-

-

49 (42.24)

-

-

120 (44.61)

-

-

53 (39.20)

-

-

Age category

0 - 50

38 (56.72)

0.78

0.46

131 (57.21)

0.62

0.09

64 (62.14)

0.95

0.84

66 (56.90)

0.98

0.97

156 (57.99)

1.19

0.55

73 (54.07)

0.925

0.773

51 - 100

18 (26.87)

R

-

60 (26.20)

R

-

26 (25.24)

R

-

26 (22.41)

R

-

58 (21.56)

R

-

30 (22.22)

R

-

101 - 150

7 (10.45)

0.51

0.20

34 (14.85)

0.59

0.15

10 (9.71)

0.47

0.08

19 (16.38)

1.11

0.77

46 (17.10)

1.87

0.13

27 (20.00)

1.62

0.17

151 - 200

4 (5.95)

2.9

0.14

4 (1.75)

0.32

0.11

3 (2.91)

1.12

0.88

5 (4.31)

2.79

0.15

9 (3.35)

-

-

5 (3.70)

2.25

0.25

Symptoms

D

33 (49.25)

1.67

0.07

123 (53.71)

0.97

0.89

53 (51.5)

0.86

0.54

70 (60.34)

1.46

0.09

167 (62.08)

3.6

0.00

82 (60.74)

1.54

0.05

ND

34 (50.75)

R

-

106 (46.29)

R

-

50 (48.5)

R

-

46 (39.66)

R

-

102 (37.92)

R

-

53 (39.26)

R

-